United Therapeutics
UTHR
UTHR
302 hedge funds and large institutions have $3.3B invested in United Therapeutics in 2019 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 86 increasing their positions, 132 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
302
Holders Change
-18
Holders Change %
-5.63%
% of All Funds
6.63%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.13%
New
32
Increased
86
Reduced
132
Closed
50
Calls
$33.1M
Puts
$31.2M
Net Calls
+$1.86M
Net Calls Change
+$9.28M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
$116M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
$37.5M |
| 3 |
Nuveen Asset Management
Chicago,
Illinois
|
$34.9M |
| 4 |
Invesco
Atlanta,
Georgia
|
$20.8M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
$27.1M |
Top Sellers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
$42.8M |
| 2 |
Goldman Sachs
New York
|
$20.8M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
$64.1M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
$174M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$7.62M |
